Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "CHEMI"

1096 News Found

Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels
Packaging | April 24, 2026

Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels

Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control


IMCD appoints Angelique Kruif as Global People Director
People | April 23, 2026

IMCD appoints Angelique Kruif as Global People Director

Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations


Evonik bets €80 million on biotech expansion to power next-gen pharma growth
Biotech | April 23, 2026

Evonik bets €80 million on biotech expansion to power next-gen pharma growth

The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform


Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies
R&D | April 22, 2026

Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies

Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research


Zyax Chem takes 26% stake in Gaymed Labs
News | April 22, 2026

Zyax Chem takes 26% stake in Gaymed Labs

Targets high-growth eye care expansion push


Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%
Sustainability | April 22, 2026

Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials


Bayer flags major Phase III results for stroke prevention drug asundexian
Clinical Trials | April 17, 2026

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy